59th annual conference of indian society of ... 2018_final.pdf savarkar marg, mahim, mumbai 400 016,

Download 59th Annual Conference of Indian Society of ... 2018_Final.pdf Savarkar Marg, Mahim, Mumbai 400 016,

If you can't read please download the document

Post on 17-Mar-2020




0 download

Embed Size (px)


  • 1

    59th Annual Conference of Indian

    Society of Gastroenterology

    ISGCON 2018, KOCHI

    Abstract Book

  • 2

    Scientific Papers Presentation Schedule

    59th ISGCON 2018

    Lulu Bolgaty Convention Center


    Date of


    Subject/Category Abstract number Venue of


    Nov 29, 2018 Plenary Session Abstract 1 to 6 Hall A 1100-1300 hrs Young Investigator Award


    Abstract 7 to 12

    Presidential Posters Abstract 13 to 64 ePoster presentation


    ePosters will be

    displayed from 9.00

    till 18.00 hrs

    Each ePanel will

    display 10 papers

    Judges will visit the

    poster area between

    1300-1400 hrs (Lunch


    Esophagus Abstract 65 to 80

    Stomach Abstract 81 to 96

    Small Intestine Abstract 97 to112

    Large Intestine Abstract 113 to145

    Motility Disorders Abstract 146 to 154

    Ped Gastroenterology Abstract 155 to 166

    Epidemiology Abstract 167 to 169

    Nov 30, 2018 Liver Abstract 170-306

    Biliary Tract Abstract 307-322

    Dec 1, 2018 Pancreas Abstract 323-361

    Endoscopy Abstract 362-414

    Nutrition Abstract 415-422

    Case Reports Abstract 423-453

  • 3

    Guidelines for e-Poster Submission – ISGCON2018

    Electronic Posters or e-Posters are similar to traditional paper/flex posters but displayed on

    site on a 50” display. All accepted posters will be displayed on e-Poster stations.

    Please note that, there will not be any physical posters at the ISGCON2018

    The format/size of the posters should be in PowerPoint, Landscape, one slide only, which

    should be in 16:9 ratio.By default, newer versions of PowerPoint use 16:9 ratio but for those

    using older versions, make sure that you change the format from standard i.e. 4:3 to wide

    screen 16:9 ratio by going to design and then to slide size in the tool bar.

    You can also make posters in pdf or jpeg format as in traditional way in 70 cm(height) x 120

    cm (width) in Landscape format. But, then these cannot be edited later if required. Please

    email the soft copy of poster to the below mentioned email id.

    Basic Rules:

    To be of value, your poster should not be too cluttered. It should be set out in a clear and

    logical manner, with reading matter reduced to an essential minimum. Lettering, including

    figure legends, labelling, symbols & graphs etc, should be large enough to be legible when

    viewed on a 50" screen. Ordinary type-face is NOT adequate. Drawings, diagrams, and

    photos are extremely helpful and often necessary to display results and conclusions. Make

    sure that your illustrations are easy to understand; do not overload any chart or drawing with


    Recommended Font and Styles:

    You should use dark text colours on a light background, or vice versa. Recommended fonts

    are Times New Roman, Calibri, Verdana and Arial, as these are easy to read, and it is

    possible that other fonts may have cross-operating system display issues.

    Videos & animations are not allowed in your e-poster

    You will be informed of your poster number as well as your computer assignment before the

    meeting. However, when you arrive at the meeting, check to confirm the day, time and

    monitor for your presentation, in case there have been last minute changes.

    Please check the sample template and also see how this will be seen on a monitor. You can

    use any template of your choice which fit your paper.

    Please note the last date for submission/upload your e-poster is 24th November 2018. All

    posters are required to be submitted much before time, but not later than Nov 24th, 2018. All

    eposters will be loaded on an ePanel by the IT personnels.

    No ePosters will be accepted at the venue. It must be sent earlier by mail.

    ePosters will be displayed everyday from 9.00 till 18.00 hrs

  • 4

    There will be approximately 20 ePanels/ screens everyday and each ePanel will display 10


    The list of Posters for a particular Screen and the Judge’s name will be displayed next to the

    screen. Presentors of those 10 papers can present to the judge on that screen by turns.

    Judges will visit the poster area between 1300-1400 hrs. Ensure your presence when the

    judges are present.

    Pl send ePoster to

    epostersisgcon2018@gmail.com or


    For queries

    You can mail to epostersisgcon2018@gmail.com

    Call Mr Ranjeeth: +91 9902902288 or 8129134010

    mailto:epostersisgcon2018@gmail.com mailto:epostersisgcon@gmail.com

  • 5


    Plenary Session …

    Young Investigator Award Session …

    Presidential Posters …

    Esophagus …

    Stomach …

    Small Intestine …

    Large Intestine …

    Motility Disorders …

    Pediatric Gastroenterology …

    Epidemiology …

    Liver …

    Biliary Tract …

    Pancreas …

    Endoscopy …

    Nutrition …

    Case Reports …

    Author Index …

    The Abstracts printed in this issue are as submitted by the Indian Society of

    Gastroenterology. In no way, the Honorary Editor-in-Chief, Editorial Board Members, or

    the printer/publishers are responsible for the results/findings and content of these Abstracts.


    Indian - Society of Gastroenterology

    Plenary Session


    Outcome of management protocol to reduce von Willebrand factor (vWF) in acute

    hepatic dysfunction: Hepatotoxicity due to yellow phosphorus (rat killer) poisoning as a


    Debasis Sardar, Nitty Mathews, Joy Mammen, S C Nair, Shibu Jacob, Mousumi Sen,

    Vijayalekshmi, K A Balasubramanian, K Subramani, Lovely Thomas, K P P Abhilash,

    Shankar Jhanwar, Ashish Goel, Uday Zachariah, Elwyn Eias, C E Eapen

    Correspondence: C E Eapen – (eapen@cmcvellore.ac.in)

    Gastroenterology and Hepatology, Christian Medical College, Vellore 632 004, India


  • 6

    Introduction: High vWF levels may predispose to platelet microthrombi and multi-organ

    failure in phosphorus poisoning induced hepatotoxicity. We report outcome of vWF lowering

    therapies: N–acetyl cysteine (NAC), fresh frozen plasma (FFP) infusions and plasma

    exchange in these patients.

    Method: In this retrospective analysis of prospectively collected data, patients were classified

    to have uncomplicated acute hepatitis/UAH (deranged LFT, INR ≤1.5), acute liver

    injury/ALI (deranged LFT, INR >1.5) and acute liver failure/ALF (ALI, hepatic

    encephalopathy). ALF patients were advised liver transplantation, those not opting for

    transplantation underwent plasma exchange and NAC infusion; ALI patients received

    NAC±FFP infusions (plasma exchange, if worsening); UAH patients had oral NAC. Normal

    plasma vWF antigen levels are 50% to 150%.

    Results: Seventeen patients with hepatotoxicity due to phosphorus poisoning (December

    2017 to July 2018), at presentation had UAH (one 19 year old male), ALI (13 patients, age 22

    (15-35) years, median (range); 6 males)) or ALF (3 patients, age 25 (7-25) years; 1 male).

    Baseline MELD scores were 11, 24 (12-38) and 36 (32-37); platelet counts were 1.59, 2

    (1.05–3.51), and 1.63 (0.9–2.92), and plasma vWF antigen levels were 153%, 392 (146-

    513)% and 448 (414- 555)% in UAH, ALI and ALF patients respectively. All 13 ALI

    patients received NAC, 7 had FFP infusion, 3 had plasma exchange (2 (1-2) sessions). All 3

    ALF patients had NAC and plasma exchange (5 (1-6) sessions). 11/13 (85%) ALI patients

    survived, 2 progressed to ALF and died. Of 3 ALF patients, 2 (67%) survived. No patient

    underwent liver transplantation. Of 5 patients meeting criteria for emergency liver

    transplantation, 3 (60%) survived.

    Conclusion: vWF lowering treatment in phosphorus poisoning induced hepatotoxicity

    resulted in transplant free survival rates of 100% (UAH), 85% (ALI) and 67% (ALF).


    Optimizing infliximab therapy using a Dashboard approach – An Indian experience

    Mihika B Dave,1 Alpa Dherai,1 Devendra Desai,2 Diane Mould,3 Tester Ashavaid,1

    Correspondence: Devendra Desai- (devendracdesai@gmail.com) 1Department of Biochemistrty, 2Division of Gastroenterology, P D Hinduja Hospital, Veer

    Savarkar Marg, Mahim, Mumbai 400 016, India, and 3Projections Research Inc.,

    Phoenixville, Pennsylvania, USA

    Introduction: Infliximab (IFX) pharmacokinetics is influenced by several variables. A few

    patients fail to respond (primary non-responders) while there are others who form antibodies

    and loose response with time (secondary non-responders). The complex multifactorial

    relationship between covariates and IFX distribution limits a direct correlation between dose

    and dru


View more >